Medical Billing Companies for Infectious Disease Practices in Tennessee

SUNLENCA is a prescription treatment used for certain adults with multidrug-resistant HIV-1 infection when the virus is resistant to several antiretroviral medicines, the patient cannot otherwise construct a fully suppressive regimen, and the medication is used with other antiretroviral agents. Treatment decisions, eligibility, dosing, and monitoring should be determined by the prescribing clinician and current product information.

Services can include claims management, coding review, claim scrubbing, rejection clearing, denial management, authorization support, payment reconciliation, A/R follow-up, credentialing, payer enrollment, contract compliance review, reporting, and revenue-cycle consulting. The work can address office visits, hospital consults, infusion, OPAT, drug claims, and related payer or coverage arrangements.

Infusion and OPAT billing requires coordination across eligibility, authorization, documentation, drug acquisition, administration charges, coding, claims submission, and payment follow-up. A focused review can identify gaps between the therapy delivered and the charges or reimbursement received. It can also clarify whether services fall under a medical or pharmacy benefit and where workflow controls need improvement.

Yes. Payment reconciliation compares received payments with expected reimbursement for drug, administration, and E/M claims. The review can flag short-pays, incorrect fee schedule application, unit or NDC mismatches, and other discrepancies. Findings can then be documented, disputed, and tracked so the practice has a clearer view of recoverable revenue and recurring payer issues.

Denials can be categorized by root cause, such as missing authorization, drug and administration coding issues, medical-versus-pharmacy benefit confusion, or incomplete consult documentation. Payer-specific appeals can be supported with relevant clinical documentation. The resulting patterns can also be shared with clinical, coding, and front-office teams to reduce repeat errors rather than treating each denial as an isolated event.

Revenue-cycle consulting can review the workflow from referral through first dose and final payment. Areas include documentation, coding, eligibility, prior authorization, drug acquisition, billing, collections, and payer or hospital coverage agreements. This gives a practice a prioritized way to evaluate operational readiness and identify financial controls before new infusion or OPAT activity becomes difficult to manage.

A useful review may include workflow documentation, payer and service-line reporting, claim and denial patterns, payment records, A/R details, contract terms, authorization procedures, and information about infusion or OPAT operations. The appropriate inputs vary by practice. Where figures are unavailable or not verified, the analysis should identify the gap rather than substitute a generalized rate or margin.

Yes. Support can be structured around specific gaps or backlogs rather than replacing every internal function. Options may include overflow claims work, rejection clearing, denial follow-up, A/R recovery, reporting, payment review, or broader workflow consulting. The scope can be aligned with the practice’s systems, staffing, service lines, and operational priorities.